We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
내부자 거래(Form 4) 신고가 제출되었습니다.
내부자 거래(Form 4) 신고가 제출되었습니다.
내부자 거래(Form 4) 신고가 제출되었습니다.
내부자 거래(Form 4) 신고가 제출되었습니다.
Consensus vs. actual, and revenue trend
| 분기 | 발표일 | 시각 | EPS 예상 | EPS 실제 | 서프라이즈 | 매출 예상 | 매출 실제 | 상태 |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 05. | 장 마감 후 (AMC) | $9.58 | — | — | $103.99B | — | 예정 |
| FY2026 Q3 | 2026. 02. 04. | 시각 미정 | — | $15.8 | — | — | $268.23B | 보고됨 |
| FY2026 Q2 | 2025. 11. 06. | 시각 미정 | — | $8.89 | — | — | $172.93B |
Consensus PT $949.73 · 15 analysts
| 날짜 | 리서치펌 | 애널리스트 | 액션 | 의견 변화 | 목표가 | 리포트 |
|---|---|---|---|---|---|---|
| 2026. 05. 15. | Citigroup | — | 의견 유지 | Buy → Buy | — | Citigroup: Buy |
| 2026. 05. 12. | Wells Fargo | — | 의견 유지 | Equal-Weight → Equal-Weight | — | Wells Fargo: Equal-Weight |
동일 리서치펌의 과거 의견 변화, 동일 섹터 내 다른 종목 액션과 비교 가능
내부자 거래(Form 4) 신고가 제출되었습니다.
내부자 거래(Form 4) 신고가 제출되었습니다.
내부자 거래(Form 4) 신고가 제출되었습니다.
내부자 거래(Form 4) 신고가 제출되었습니다.
내부자 거래(Form 4) 신고가 제출되었습니다.
내부자 거래(Form 4) 신고가 제출되었습니다.
| FY2026 Q1 | 2024. 06. 30. | 시각 미정 | — | $7 | — | — | $79.28B | 보고됨 |
Automated summary from public sources · not investment advice
공시·실적·기관 변화를 한국어 한 단락으로 요약. 원문 출처와 함께 제공됩니다.
Ranked by position value
| # | 기관 | 운용 형태 | 보유 주식 | 평가액 | 비중 | 변화율 | 포지션 |
|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 15,880 | $13.03B | 0.02% | — | 신규 편입 |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 6,198 | $5.36B | 0.00% | — | 신규 편입 |
신규 편입·전량 매도·비중 변화까지 모두 확인할 수 있습니다.
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Stored first · Google News · Yahoo Finance (English)
McKesson’s ASCO 2026 Data Highlights Evolving Role In Community Oncology - simplywall.st
McKesson’s ASCO 2026 Data Highlights Evolving Role In Community Oncology simplywall.st
McKesson Expands Gene Therapy Role With Nanoscope InspiroGene Partnership - simplywall.st
McKesson Expands Gene Therapy Role With Nanoscope InspiroGene Partnership simplywall.st
Analysts Offer Insights on Healthcare Companies: Phreesia (PHR), McKesson (MCK) and Biohaven Ltd. (BHVN) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Phreesia (PHR), McKesson (MCK) and Biohaven Ltd. (BHVN) The Globe and Mail
Owens & Minor names former McKesson VP as new CEO - MassDevice
Owens & Minor names former McKesson VP as new CEO MassDevice
Assessing McKesson (MCK) Valuation After Recent Share Price Weakness And Cooling Long Term Momentum - simplywall.st
Assessing McKesson (MCK) Valuation After Recent Share Price Weakness And Cooling Long Term Momentum simplywall.st